ACTIVE SUBSTANCE / INN

POLATUZUMAB VEDOTIN

Brand name(s): Polivy
EMA LISTED
AUTHORISED
Lymphoma, B-Cell
ACTIVE SUBSTANCE
Polatuzumab Vedotin
REGULATORS
EMA
SPONSORS / MAH
Roche Registration GmbH
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
PolivyRoche Registration GmbHAuthorised16/01/2020Lymphoma, B-Cell

FULL INTELLIGENCE ON POLATUZUMAB VEDOTIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →